<p>Christine Fox, EVP, Head of U.S. Commercial at Teva Pharmaceutical Industries Ltd., has reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Teva Pharmaceutical Industries Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-286134), on November 18, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

TEVA

<p>Christine Fox, EVP, Head of U.S. Commercial at Teva Pharmaceutical Industries Ltd., reported the disposal of common shares of the company. The filing is available via EDGAR, the SEC's system.</p>

Teva EVP Head of U.S. Commercial Christine Fox Reports Disposal of Common Shares